<?xml version="1.0" encoding="UTF-8" ?>
<sigrec-multi-trials-transfert
	xmlns="http://sigrec.ClinicalTrialApplication.xsd">
	<multi-trial>
		<trial trial-interne-identification="C98851009"
			trial-sigrec-identification="SIGREC-0021A">
			<sponsor-information>
				<sponsor>
					<ev-sponsor-sender-id>BAYER Santé</ev-sponsor-sender-id>
					<sponsor-type type-id="1" />
					<sponsor-contact-details>
						<organisation>Organisation Bayer</organisation>
						<address>2 rue de paris</address>
						<post-code>44300</post-code>
						<town-city>Nantes</town-city>
						<telephone>0212457898</telephone>
						<fax>0212457895</fax>
						<email>mail@bayer.chunantes.fr</email>
					</sponsor-contact-details>
					<sponsor-intervenants>
						<intervenant intervenant-id="2">
							<civilite>Mr</civilite>
							<num-adeli>0123456</num-adeli>
							<id>0123456</id>
							<nom>Arc Bayer</nom>
							<prenom>Jean</prenom>
							<titre>Arc Promoteur</titre>
							<service>
								<id>1</id>
								<libelle>1</libelle>
								<date-arrivee>2008-12-12</date-arrivee>
								<date-depart>2012-12-12</date-depart>
								<coordonnees>
									<address>dsd</address>
									<email>email</email>
									<family-name>family-name</family-name>
									<fax>fax</fax>
									<given-name>given name</given-name>
									<middle-name>modle name</middle-name>
									<organisation>organisation</organisation>
									<post-code>post code</post-code>
									<telephone>telephone</telephone>
									<town-city>tow</town-city>
								</coordonnees>
							</service>
							<fonctions>
								<fonction-id>201</fonction-id>
								<fonction-libelle>201</fonction-libelle>
							</fonctions>
						</intervenant>
					</sponsor-intervenants>
				</sponsor>
			</sponsor-information>
			<trial-identification>
				<abbreviated-title-trial na="N">Bayer Paracétamol</abbreviated-title-trial>
				<eudract-number>EDRACT 11</eudract-number>
				<full-title-trial>Essai Bayer sur l'impcat du paracétamol dans les mots de tetes</full-title-trial>
			</trial-identification>
			<general-information>
				<planned-end-date>2011-01-01</planned-end-date>
				<planned-start-date>2009-10-8</planned-start-date>
				<total-trial-duration-ms-months>18</total-trial-duration-ms-months>
				<trial-scope>
					<dépistage>Y</dépistage>
				</trial-scope>
				<trial-design>
					<double-blind>N</double-blind>
					<single-blind>N</single-blind>
					<number-of-sites>4</number-of-sites>
					<number-of-sites-open>1</number-of-sites-open>
				</trial-design>
				<trial-type-and-phase>
					<phase-two-a>Y</phase-two-a>
					<phase-four>N</phase-four>
				</trial-type-and-phase>
				<objet-recherche>
					<imagerie>N</imagerie>
					<radiothérapie>Y</radiothérapie>
				</objet-recherche>
				<type-recherche>
					<soins-courants>Y</soins-courants>
					<observationnelle>N</observationnelle>
				</type-recherche>
			</general-information>
			<regulatory-information>
				<insurance-information>
					<insurance>
						<insurance-policy-number>Assur-1321</insurance-policy-number>
						<beginning-validity-date>2009-02-02</beginning-validity-date>
						<end-validity-date>2011-01-02</end-validity-date>
						<given-name idnat="0">AXA</given-name>
						<adress>2 rue de Poitiers</adress>
						<post-code>44100</post-code>
						<town-city>Nantes</town-city>
						<country-iso-code>1</country-iso-code>
						<amendments></amendments>
					</insurance>
				</insurance-information>
				<cro>
					<organization national-id="4" node-id="4">
						<adress>54 rue de Besançon</adress>
						<given-name>QUINTILES</given-name>
						<post-code>44100</post-code>
						<town-city>Nantes</town-city>
					</organization>
				</cro>
			</regulatory-information>
			<proposed-clinical-trial-sites>
				<investigator>
					<sponsor-investigator-number>127</sponsor-investigator-number>
					<type-investigator>1</type-investigator>
					<institution-finess>fin123</institution-finess>
					<institution-name>Centre 127</institution-name>
					<contact-details>
						<address>3 rue ttt </address>
						<email>centre1@ggg.cc</email>
						<family-name>Dupond</family-name>
						<fax>0245124512</fax>
						<given-name>Centre 1</given-name>
						<middle-name>Centre 1</middle-name>
						<organisation>Centre 1</organisation>
						<post-code>44000</post-code>
						<telephone>021542124</telephone>
						<town-city>Nantes</town-city>
					</contact-details>
					<intervenants>
						<intervenant intervenant-id="212">
							<civilite>Mlle</civilite>
							<id>2222</id>
							<num-adeli>numero adeli investigateur principal</num-adeli>
							<prenom>Annie</prenom>
							<nom>David</nom>
							<titre>Docteur</titre>
							<fonctions>
								<fonction-id>101</fonction-id>
								<fonction-libelle>101</fonction-libelle>
							</fonctions>
							<service>
								<id>1</id>
								<libelle>1</libelle>
								<date-arrivee>2008-02-02</date-arrivee>
								<date-depart>2014-02-02</date-depart>
								<coordonnees></coordonnees>
							</service>
						</intervenant>

						<intervenant intervenant-id="321">
							<civilite>Mr</civilite>
							<id>4444</id>
							<num-adeli>numero adeli ARC Inves</num-adeli>
							<prenom>Ronald</prenom>
							<nom>Vincent</nom>
							<titre>ARC</titre>
							<fonctions>
								<fonction-id>104</fonction-id>
								<fonction-libelle>104</fonction-libelle>
							</fonctions>
							<service>
								<id>5</id>
								<libelle>5</libelle>
								<date-arrivee>2006-02-02</date-arrivee>
								<date-depart>2012-02-02</date-depart>
								<coordonnees></coordonnees>
							</service>
						</intervenant>
					</intervenants>
				</investigator>
			</proposed-clinical-trial-sites>
		</trial>
	</multi-trial>
</sigrec-multi-trials-transfert>